In the Spotlight
No free ride on U.S. innovation.
Pharmaceutical price controls hurt Euro zone competitiveness.
John Vernon, Joseph H. Golec, Medical Progress Today, 7-20-07
The typical U.S. consumer is willing to pay up for superior–quality high–technology products, e.g., Blackberry Smartphones®, because they understand that such products provide value for the money. Furthermore, they understand that paying a higher price provides an incentive to successful, innovative companies to spend on research and development that leads to new innovative products and increased competition—witness Apple's iPhone.
Continue reading . . .
· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11
More Headlines >>
Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.
For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at firstname.lastname@example.org, or via telephone at 212.599.7000.
Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at email@example.com, or via telephone at 212.599.7000.
If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.